Nicola Cotugno Selected Research

Down Syndrome (Down's Syndrome)

1/2022

Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Cotugno Research Topics

Disease

12	COVID-19 12/2023 - 11/2020
9	HIV Infections (HIV Infection) 05/2024 - 04/2013
7	Inflammation (Inflammations) 01/2024 - 01/2019
7	Infections 01/2022 - 01/2012
5	Human Influenza (Influenza) 01/2019 - 03/2012
3	Myocarditis (Carditis) 10/2023 - 01/2023
3	Measles 01/2022 - 03/2015
2	Fever (Fevers) 08/2023 - 07/2023
2	Viremia 07/2023 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2019
2	Neuroblastoma 01/2022 - 08/2021
2	Neoplasms (Cancer) 01/2022 - 01/2022
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 04/2013
2	Chronic Granulomatous Disease 01/2018 - 03/2015
1	Edema (Dropsy) 08/2023
1	Chest Pain (Chest Pains) 08/2023
1	Pulmonary Aspergillosis 07/2023
1	Pericarditis 01/2023
1	Pericardial Effusion 01/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Cryptosporidiosis 01/2023
1	Down Syndrome (Down's Syndrome) 01/2022
1	Dermatitis 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Colitis 01/2022
1	Reinfection 01/2022
1	Eosinophilia 01/2022
1	Cytokine Release Syndrome 11/2020
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2020
1	Virus Diseases (Viral Diseases) 07/2019
1	Dysbiosis 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019
1	Tetanus 01/2019
1	Failure to Thrive 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2019
1	Coinfection 01/2019
1	Vaccine-Preventable Diseases 09/2016
1	Primary Immunodeficiency Diseases 03/2015
1	Pneumonia (Pneumonitis) 06/2013
1	Respiratory Insufficiency (Respiratory Failure) 06/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2013
1	Kidney Diseases (Kidney Disease) 01/2012

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 08/2023 - 03/2012
4	Messenger RNA (mRNA)IBA 12/2023 - 01/2022
4	AntigensIBA 12/2023 - 01/2017
3	AntibodiesIBA 12/2023 - 02/2016
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2022
3	BNT162 VaccineIBA 08/2023 - 01/2022
3	EnzymesIBA 08/2023 - 02/2014
2	RNA (Ribonucleic Acid)IBA 01/2024 - 07/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2020
2	CytokinesIBA 01/2024 - 11/2020
2	mRNA VaccinesIBA 12/2023 - 10/2023
2	Notch ReceptorsIBA 01/2023 - 04/2022
2	LigandsIBA 01/2022 - 07/2019
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2021
2	NectinsIBA 01/2022 - 07/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 03/2015
2	ImmunosorbentsIBA 09/2016 - 02/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	COVID-19 VaccinesIBA 08/2023
1	liposomal amphotericin B FDA Link 07/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2023
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2023
1	Caspofungin (Cancidas)FDA Link 07/2023
1	TroponinIBA 01/2023
1	CD40 Ligand (CD40L)IBA 01/2023
1	pro-brain natriuretic peptide (1-76)IBA 01/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	nutlin 3IBA 01/2022
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	remdesivirIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 08/2021
1	Neutralizing AntibodiesIBA 01/2021
1	InterleukinsIBA 11/2020
1	AutoantibodiesIBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 02/2016
1	Toll-Like Receptor 9IBA 03/2015
1	Ribavirin (Virazole)FDA LinkGeneric 06/2013
1	SteroidsIBA 06/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2013

Therapy/Procedure

9	Art Therapy 05/2024 - 01/2012
8	Therapeutics 11/2023 - 06/2013
1	Immunotherapy 07/2019
1	Transplantation 09/2016
1	Extracorporeal Membrane Oxygenation 06/2013
1	Highly Active Antiretroviral Therapy (HAART) 04/2013